{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:14:31Z","timestamp":1793682871845,"version":"4.5.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020991","name":"Riphah International University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpet.2025.103681","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T03:13:02Z","timestamp":1756437182000},"page":"103681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antithrombotic potential of lornoxicam and possible mechanistic pathways"],"prefix":"10.1016","volume":"392","author":[{"given":"Waseem","family":"Khalid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif-ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2025.103681_bib1","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2023.2301633","article-title":"Understanding thrombosis: the critical role of oxidative stress","volume":"29","author":"Li","year":"2024","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.jpet.2025.103681_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5334\/gh.1288","article-title":"The heart of the world","volume":"19","author":"Di Cesare","year":"2024","journal-title":"Glob Heart"},{"issue":"14","key":"10.1016\/j.jpet.2025.103681_bib3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Global Cardiovascular Risk Consortium","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jpet.2025.103681_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31083\/j.rcm2508281","article-title":"Current antithrombotic treatments for cardiovascular diseases: a comprehensive review","volume":"25","author":"Galanti","year":"2024","journal-title":"Rev Cardiovasc Med"},{"issue":"02","key":"10.1016\/j.jpet.2025.103681_bib5","first-page":"572","article-title":"Literature review: study of molecular mechanism level of NSAID class of drugs as COX-2 inhibitors","volume":"13","author":"Zakiyah","year":"2022","journal-title":"Jurnal Eduhealth"},{"issue":"10","key":"10.1016\/j.jpet.2025.103681_bib6","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1517\/14656566.3.10.1501","article-title":"Meloxicam","volume":"3","author":"Fleischmann","year":"2002","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10.1016\/j.jpet.2025.103681_bib7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2174\/1570180819666220922103109","article-title":"Molecular docking: principles, advances, and its applications in drug discovery","volume":"21","author":"Muhammed","year":"2024","journal-title":"Lett Drug Des Discov"},{"issue":"7","key":"10.1016\/j.jpet.2025.103681_bib8","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jpet.2025.103681_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285965","article-title":"Comprehensive in silico analyses of flavonoids elucidating the drug properties against kidney disease by targeting AIM2","volume":"18","author":"Kandeel","year":"2023","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jpet.2025.103681_bib10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.tibs.2019.06.004","article-title":"Bringing molecular dynamics simulation data into view","volume":"44","author":"Hildebrand","year":"2019","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jpet.2025.103681_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2022.100895","article-title":"Reprofiling analysis of FDA approved drugs with upregulated differential expression genes found in hypertension","volume":"29","author":"Ali","year":"2022","journal-title":"Inform Med Unlocked"},{"issue":"1","key":"10.1016\/j.jpet.2025.103681_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pro.3923","article-title":"The Bio3D packages for structural bioinformatics","volume":"30","author":"Grant","year":"2021","journal-title":"Protein Sci"},{"issue":"2","key":"10.1016\/j.jpet.2025.103681_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/cphc.202200491","article-title":"On the uses of PCA to characterise molecular dynamics simulations of biological macromolecules: basics and tips for an effective use","volume":"24","author":"Palma","year":"2023","journal-title":"Chemphyschem"},{"issue":"5","key":"10.1016\/j.jpet.2025.103681_bib14","first-page":"969","article-title":"Synthesis, docking, antioxidant, antihyperlipidemic, antiplatelet, anticoagulant, and vasodilatory activities of isoxazole newly synthesized derivative","volume":"39","author":"Kanwal","year":"2020","journal-title":"Lat Am J Pharm"},{"issue":"3","key":"10.1016\/j.jpet.2025.103681_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.thromres.2006.01.019","article-title":"Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12\u00ae rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study","volume":"119","author":"Malinin","year":"2007","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.jpet.2025.103681_bib16","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.3892\/mmr.2015.3319","article-title":"Chloroform fraction of Euphorbia maculata has antiplatelet activity via suppressing thromboxane B2 formation","volume":"11","author":"Kwon","year":"2015","journal-title":"Mol Med Rep"},{"issue":"8","key":"10.1016\/j.jpet.2025.103681_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2174\/1573406412666160502153417","article-title":"Synthesis, anticlotting and antiplatelet effects of 1,2,3-triazoles derivatives","volume":"12","author":"Moura","year":"2016","journal-title":"Med Chem"},{"issue":"1","key":"10.1016\/j.jpet.2025.103681_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40816-023-00353-8","article-title":"Antioxidant, cytotoxic, antibacterial and thrombolytic activities of Centella asiatica L.: possible role of phenolics and flavonoids","volume":"9","author":"Rashid","year":"2023","journal-title":"Clin Phytosci"},{"key":"10.1016\/j.jpet.2025.103681_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7847142","article-title":"Effects of curcumin nanoparticles in isoproterenol-induced myocardial infarction","volume":"2019","author":"Boarescu","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"10.1016\/j.jpet.2025.103681_bib20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jsps.2017.04.024","article-title":"The effects of low-molecular-weight heparin on lung and pulmonary artery injuries in acute pulmonary embolism rat model via platelet-derived growth factor-\u03b2","volume":"25","author":"Zhou","year":"2017","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.jpet.2025.103681_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116657","article-title":"Enhanced cardioprotective activity of ferulic acid-loaded solid lipid nanoparticle in an animal model of myocardial injury","volume":"476","author":"Ishtiaq","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103681_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/biom10030443","article-title":"Succinamide derivatives ameliorate neuroinflammation and oxidative stress in scopolamine-induced neurodegeneration","volume":"10","author":"Iqbal","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpet.2025.103681_bib23","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3389\/fphar.2020.01220","article-title":"A potent antioxidant endogenous neurohormone melatonin, rescued MCAO by attenuating oxidative stress-associated neuroinflammation","volume":"11","author":"Ling","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2025.103681_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119033","article-title":"Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity","volume":"577","author":"Khan","year":"2020","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.jpet.2025.103681_bib25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjcard.2007.11.054","article-title":"The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers","volume":"101","author":"Gladding","year":"2008","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.jpet.2025.103681_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1017\/S0265021508004274","article-title":"Preemptive analgesia by lornoxicam\u2013an NSAID\u2013significantly inhibits perioperative platelet aggregation","volume":"25","author":"Felfernig","year":"2008","journal-title":"Eur J Anaesthesiol"},{"issue":"6","key":"10.1016\/j.jpet.2025.103681_bib27","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/molecules25061375","article-title":"A review on applications of computational methods in drug screening and design","volume":"25","author":"Lin","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jpet.2025.103681_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","article-title":"Automated docking of flexible ligands: applications of AutoDock","volume":"9","author":"Goodsell","year":"1996","journal-title":"J Mol Recognit"},{"key":"10.1016\/j.jpet.2025.103681_bib29","article-title":"Protein\u2013Ligand Binding Thermodynamics","author":"Miller","year":"2023","journal-title":"American Chemical Society"},{"issue":"1","key":"10.1016\/j.jpet.2025.103681_bib30","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/s41598-020-58730-z","article-title":"Study of structural stability and formation mechanisms in DSPC and DPSM liposomes: a coarse-grained molecular dynamics simulation","volume":"10","author":"Hashemzadeh","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jpet.2025.103681_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119264","article-title":"Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis","volume":"10","author":"Mart\u00ednez","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jpet.2025.103681_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/147323000603400206","article-title":"The effect of pre-operative lornoxicam and ketoprofen application on the morphine consumption of post-operative patient-controlled analgesia","volume":"34","author":"Karaman","year":"2006","journal-title":"J Int Med Res"},{"issue":"3","key":"10.1016\/j.jpet.2025.103681_bib33","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood.V88.3.907.907","article-title":"Analysis of GPIIb\/IIIa receptor number by quantification of 7E3 binding to human platelets","volume":"88","author":"Wagner","year":"1996","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jpet.2025.103681_bib34","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/iub.1334","article-title":"Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond","volume":"66","author":"Xu","year":"2014","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jpet.2025.103681_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6437641","article-title":"Sundarban honey confers protection against isoproterenol-induced myocardial infarction in Wistar rats","volume":"2016","author":"Afroz","year":"2016","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.jpet.2025.103681_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1139\/y03-023","article-title":"Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor","volume":"81","author":"Saito","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103681_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.CIR.0000025261.58465.62","article-title":"Cyclooxygenase-2 inhibition and cardiovascular events","volume":"106","author":"Pitt","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jpet.2025.103681_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.jpet.2025.103681_bib39","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ Res"},{"issue":"13","key":"10.1016\/j.jpet.2025.103681_bib40","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.3390\/diagnostics13132301","article-title":"Diagnostic blood biomarkers for acute pulmonary embolism: a systematic review","volume":"13","author":"Wikan","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"10.1016\/j.jpet.2025.103681_bib41","first-page":"RA209","article-title":"Oxidative stress and ischemic myocardial syndromes","volume":"15","author":"Misra","year":"2009","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.jpet.2025.103681_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/157340310793566118","article-title":"Mechanisms of the beneficial actions of ischemic preconditioning on subcellular remodeling in ischemic-reperfused heart","volume":"6","author":"M\u00fcller","year":"2010","journal-title":"Curr Cardiol Rev"},{"issue":"2","key":"10.1016\/j.jpet.2025.103681_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0163-7258(00)00114-5","article-title":"Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications","volume":"89","author":"Wattanapitayakul","year":"2001","journal-title":"Pharmacol Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:57:53Z","timestamp":1761850673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022356525398940"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103681","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic potential of lornoxicam and possible mechanistic pathways","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103681"}}